Skip to main content

Find Clinical Trials

Home
Conditions
Nevi and Melanomas

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies

Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

NCT00042783

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

NCT00019331

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +88 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00019734

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019669

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019487

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00058279

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019721

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants

NCT00416988

Conditions: Body Weight, Body Weight Changes, Melanoma, +15 more
Locations: Not specified

View Trial Details

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019214

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

NCT00082914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details